Thank you, Kurt. Starting on Slide 9. I’ll provide a review of our second quarter 2023 financial performance. Total sales, including our proportionate 50% share of sales from the Zeolyst Joint Venture were $229 million compared to $261 million in the second quarter of last year. Of the period-over-period change, approximately $32 million is directly associated with a pass-through of lower sulfur costs compared to the second quarter of 2022. In addition, volume was lower during the quarter compared to the prior year. Sales volume for virgin sulfuric acid was lower, largely due to the production limitations during the quarter that Kurt referenced. Silica Catalyst sales decreased due to weaker global demand for polyethylene as well as timing for event-driven niche custom catalyst used for the production of methyl methacrylate. The lower volume was offset by higher pricing and regeneration services and in silica catalysts. Within our Zeolyst Joint Venture, sales were up 25%, on higher sales of catalyst used in the production of renewable fuels, emission control and hydrocracking catalyst compared to the second quarter of the prior year. Adjusted EBITDA for the second quarter was $79 million, up 9% compared to the second quarter of 2022, driven by higher pricing and regeneration services as well as favorable sales mix and higher pricing in Catalyst Technologies. This more than offset lower sales volume and higher unplanned repair and maintenance costs in Ecoservices during the quarter. The adjusted EBITDA margin for the second quarter of 2023 was nearly 35%, up close to 700 basis points compared to 28% in the second quarter of last year, illustrating the impact that changes in sulfur costs and the associated pass-through has on the margin calculation. Approximately 440 basis points of the increase is related to the pass-through of lower sulfur cost. The balance of the margin improvement was largely a function of higher pricing across both businesses and higher volume in the Zeolyst joint venture, partially offset by higher costs in the quarter associated with the production downtime in Ecoservices. The next slide illustrates the drivers of the change in adjusted EBITDA compared to the prior year. During the second quarter of 2023, average sulfur prices were significantly lower than in the second quarter of the prior year. As we have previously discussed, in terms of the selling price for virgin sulfuric acid, the sulfur cost is a direct pass-through. As reflected on the bridge compared to the second quarter of last year, the impact of the pass-through of sulfur cost was approximately $32 million, which is neutral to the change in adjusted EBITDA. The increase in adjusted EBITDA for the second quarter was therefore driven by price increases exclusive of the sulfur pass-through impact, covering higher variable costs, resulting in yet another quarter of positive price-to-cost ratio. The higher price to cost benefit during the quarter more than offset the impact of lower sales volume. Turning to the second quarter results for Ecoservices on Slide 11. Ecoservices sales for the second quarter of 2023 were $158 million compared to $193 million in the second quarter of 2022. The change in Ecoservices sales was primarily driven by the $32 million pass-through impact associated with lower average sulfur costs. The lower sales volume for virgin sulfuric acid was nearly offset by higher pricing in regeneration services. Ecoservices adjusted EBITDA for the second quarter of 2023 was $60 million, unchanged compared to the year ago quarter as the benefit of higher pricing for regeneration services offset the lower sales volume for virgin sulfuric acid and higher costs largely associated with the production outages during the quarter. For the second quarter, the Ecoservices adjusted EBITDA margin was 38%, up nearly 700 basis points compared to the year ago quarter. The margin increase is primarily driven by the impact from the pass-through of lower sulfur costs as the higher pricing offset higher variable and fixed costs compared to the second quarter of 2022. Catalyst Technologies, second quarter 2023 total sales, including the Zeolyst Joint Venture were $71 million, up 4% compared to the second quarter of last year. Silica Catalyst sales for the second quarter were $26 million compared to $32 million in the second quarter of 2022. The decrease in silica catalyst sales was driven by lower sales of polyethylene catalysts and the timing of event-driven niche custom catalyst orders used in the production of methyl methacrylate. Second quarter sales for the Zeolyst Joint Venture were $45 million, up $9 million or 25% compared to the second quarter of 2022 on the higher sales of renewable fuels, mission control and hydrocracking catalyst. Second quarter adjusted EBITDA for Catalyst Technologies was $25 million, up 19% compared to the year ago quarter. The increase was driven by the higher pricing, favorable mix and higher sales volume within the Zeolyst Joint Venture, partially offset by the lower sales volume for Silica Catalyst. The adjusted EBITDA margin for Catalyst Technologies was 36%, a 450 basis points compared to the second quarter of last year on higher pricing and increased sales of higher margin products within the Zeolyst Joint Venture. Turning to our discussion on cash, leverage and liquidity. As we have previously discussed, our business has historically demonstrated a strong cash generation capability. With a cash conversion ratio of nearly 80% in 2022, our adjusted free cash flow of $146 million provided for a significant capital allocation flexibility including the repurchase of $137 million of stock in conjunction with secondary offerings. We expect cash conversion for this year to remain above 75%, while we were a net user of cash in the first quarter of the year we generated significant operational cash flow in the second quarter. Cash from operations in the first half of the year was $41 million compared to $53 million in the first half of 2022. But the lower cash from operations was driven by the timing of dividends received from our Zeolyst Joint Venture. On leverage, during the first six months, we spent $73 million for share repurchases in conjunction with secondary offerings. Given the use of cash for share repurchases during the first half of the year, our net debt leverage ratio at the end of the second quarter held at 3.2 times as compared to the end of the first quarter. We expect to generate cash over the balance of the year that will provide for a reduction in our net debt leverage ratio. Based upon our current outlook and assuming no further share repurchases, we expect to end this year with a net debt leverage ratio below 3 times in line with the 2.8 times leverage ratio at the end of 2022. I would also like to highlight that leverage reduction will remain a key priority as we continue to target a net debt leverage ratio of 2 to 2.5 times. At quarter end, we had total liquidity of $99 million, comprised of cash and cash equivalents of $29 million and availability under our ABL facility of $70 million. Kurt has previously stated, late in the second quarter, we saw evidence of weaker demand fundamentals and end uses, which we believe are more influenced by cyclical global demand trends. For the second half of 2023, we believe these weaker demand fundamentals will adversely impact sales on virgin sulfuric acid into nylon production as well as sales of polyethylene catalyst, driven by declining global polyethylene demand and lower plant operating rates. With this updated view on the market as well as the unplanned operational downtime at our Ecoservices Dominguez facility late in the second quarter and carrying into the third quarter, we are adjusting our guidance to reflect our updated outlook. We now expect sales for the full year 2023 to be in the range of $685 million to $715 million, primarily due to our expected lower sales volume into nylon and polyethylene end uses. Relative to 2022, we still expect a sales decrease of approximately $90 million associated with the pass-through effect of lower average sulfur costs. At the segment level, Ecoservices sales are expected to be down on a mid-double-digit percentage basis, while Silica Catalyst sales are expected to be down year-over-year on a low double-digit percentage basis. Excluding the estimated $90 million impact of sulfur cost pass-through, Ecoservices sales are forecasted to be down approximately 3% at the midpoint of our guidance. For the Zeolyst Joint Venture, we now expect full year 2023 sales to fall in the range of $155 million to $165 million, up $10 million from our prior guidance range, reflecting our continued expectations for stronger hydrocracking and renewable fuel catalyst sales this year. Taking into account these revised sales assumptions, we now expect full year adjusted EBITDA to be in the range of $260 million to $275 million. At the segment level, compared to the prior year, we expect Ecoservices adjusted EBITDA to be lower on a high single-digit to low double-digit percentage basis coming off 2022, where Ecoservices adjusted EBITDA expanded by 28%. We anticipate Catalyst Technologies adjusted EBITDA to be up on a high single-digit to low double-digit percentage basis. Corporate costs are expected to average for the full year, what was reported in the second quarter. In light of our revised expectations for full year adjusted EBITDA, we now expect adjusted free cash flow will be in the range of $100 million to $150 million. In addition, our capital spending guidance range has been reduced, reflecting $50 million to $60 million, largely due to revised timing assumptions for capital projects. Lastly, with the interest rate caps we have in place, we still expect interest expense to be $45 million to $50 million for the year. For the second half of the year, given the lower expected sales of virgin sulfuric acid sold into the nylon market, we expect that Ecoservices adjusted EBITDA will be relatively similar in the third and fourth quarters, with Q3 earnings down 15% to 20% compared to the third quarter of 2022. For Catalyst Technologies, we anticipate that their third quarter earnings will be generally in line with the prior year’s third quarter, with higher earnings expected in the fourth quarter, driven by product mix and the timing of hydrocracking catalyst orders. Overall, for the third quarter, we expect our adjusted EBITDA to be down low double digits compared to the prior year third quarter. However, our fourth quarter will be stronger with expected adjusted EBITDA up on a low double-digit percentage basis compared to the prior year fourth quarter. I will now hand the call back to Kurt for some closing remarks.